“Matching-Adjusted Indirect Comparison (MAIC) of Deucravacitinib Versus Adalimumab for the Treatment of Patients With Moderate to Severe Plaque Psoriasis over 2 Years”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s112. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/1995.